Research programme: neurological disorder therapeutics - OrganonAlternative Names: AMPA receptor inhibitors - Organon; Ampakine compounds - Organon
Latest Information Update: 13 Oct 2010
At a glance
- Originator Organon
- Class Small molecules
- Mechanism of Action AMPA receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Major depressive disorder; Schizophrenia
Most Recent Events
- 02 Feb 2001 Preclinical development for Depression in USA (PO)
- 02 Feb 1999 Preclinical trials in Schizophrenia in USA (PO)